Telemedicine Beneficial in Management of Chronic Diseases, Lowering Costs
Historical evidence update (November 2026): This article summarizes a 2014 research review by Bashshur and colleagues, not a finding that telemedicine always improves outcomes or reduces costs. The review examined heart failure, stroke and chronic obstructive pulmonary disease, and reported promising results across selected interventions. Later systematic reviews have found mixed effects that depend on the condition, the monitoring model and the outcome measured. These findings should not be interpreted as guaranteed reductions in hospital use, mortality or spending.
Research references: 2014 original review (PubMed); 2024 systematic review of heart failure and COPD readmissions; Cochrane review of COPD telehealth technologies.
September 11, 2014 | By Katie Dvorak
A 2014 research review examined how telemedicine could support management of selected chronic diseases. Its findings varied by condition and intervention, and did not establish that every telemedicine program reduces costs.
The study, published online in the journal Telemedicine and e-Health, looks at the impact telemedicine has on cost, quality and access to care, focusing on three chronic diseases: congestive heart failure, stroke and chronic obstructive pulmonary disease.
The authors, which include former American Telemedicine Association President Rashid Bashshur –executive director of eHealth at the University of Michigan Health System–found that for each chronic disease, a different telehealth approach was needed.
- Congestive heart failure: Long-term telemonitoring was one of the approaches discussed in the 2014 review; comparative effectiveness varies by program and patient population.
- Stroke: The 2014 review discussed telestroke consultations and prompt treatment decisions as potential ways to improve access to stroke care. A 10-year evaluation reportedly found increased treatment access for rural patients and faster intervention.
- COPD: Telepulmonology approaches discussed in the review included remote lung-function measurements and consultations among patients, clinicians and pulmonary specialists; these do not constitute a single best treatment for all patients.
Because of the different types of telemedicine used for each chronic disease, the study’s authors said a “homogeneous telemedicine landscape now or in the future is beyond reasonable expectation.”
The 2014 authors reported that many included studies observed fewer hospital admissions, readmissions or emergency visits, sometimes with lower mortality. These were findings across selected studies, not benefits established for every setting.
The use of telemedicine also allows patients to be more engaged in managing their own health, according to the authors.
The 2014 article also cited a separate study reporting patient interest in video appointments; that finding should not be generalized to all patients.
The authors discussed potential cost reductions through avoided services, but actual savings depend on the care model and setting. A Towers Watson projection reported in 2014 suggested that telemedicine might save U.S. employers money; it was a forecast, not a measured outcome.
To learn more:
– check out the study (PubMed record)
Move from information to action
See how the N9+ can fit your organization.
Explore the remote physical exam platform or request a focused demonstration.